Management of atypical glandular cells and adenocarcinoma in situ.
Glandular abnormalities of the cervix remain a difficult clinical problem. It is a challenge for the clinician to manage and follow this unusual cytologic finding properly. This article highlights the definitions of glandular abnormalities, reviews current published guidelines for clinical management, and discusses the underlying rates of neoplasia associated with these cytology reports. It reviews proper follow-up of patients found not to have neoplasia and current treatment options for patients who have significant neoplasia. It also discusses the diagnosis of associated endometrial lesions and the use of human papillomavirus DNA testing in the management of glandular lesions of the lower genital tract.
Dunton
Charles J
CJ
Division of Gynecologic Oncology, Lankenau Hospital, 100 Lancaster Avenue, Wynnewood, PA 19096, USA.duntonc@mlhs.org
D000230:Adenocarcinoma / Q000473:pathology / Q000628:therapy*; D000293:Adolescent; D000328:Adult; D000368:Aged; D001706:Biopsy; D002584:Cervix Uteri / Q000166:cytology / Q000473:pathology; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D006801:Humans; D008875:Middle Aged; D027383:Papillomaviridae / Q000302:isolation & purification; D030361:Papillomavirus Infections / Q000150:complications / Q000473:pathology / Q000628:therapy; D017698:Postmenopause; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000473:pathology / Q000628:therapy*; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000628:therapy*; D014626:Vaginal Smears; D055815:Young Adult; D002578:Uterine Cervical Dysplasia / Q000473:pathology / Q000628:therapy*
D004279:DNA, Viral